Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy seeks marketing approval for Rectogesic in South Korea

March 8, 2001

Favorable data presented this week for subcutaneous anti-CD11a antibody product for psoriasis

March 7, 2001

Switch Biotech and TUM enter research alliance on atopic dermatitis

March 7, 2001

Biogen's disease-modifying psoriasis therapy maintains efficacy upon retreatment

March 7, 2001

Positive phase III results announced for Metvix PDTas treatment of actinic keratosis

March 7, 2001

Phase IIa trial results presented at AAD meeting for ABX-IL-8 in psoriasis

March 6, 2001

AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial

March 6, 2001

Sustained clinical activity reported in IDEC-114 phase I/II trial for psoriasis

March 6, 2001

FDA requests additional information for Dermagraft PMA

Feb. 27, 2001

Novel antipruritic agents in development at Pfizer

Feb. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.